{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:10:08Z","timestamp":1776748208582,"version":"3.51.2"},"reference-count":48,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medicinal University of Silesia","award":["PCN-1-041\/N\/1\/F"],"award-info":[{"award-number":["PCN-1-041\/N\/1\/F"]}]},{"name":"Medicinal University of Silesia","award":["PCN-1-091\/N\/1\/F"],"award-info":[{"award-number":["PCN-1-091\/N\/1\/F"]}]},{"name":"Medicinal University of Silesia","award":["PCN-1-045\/K\/2\/F"],"award-info":[{"award-number":["PCN-1-045\/K\/2\/F"]}]},{"name":"Medicinal University of Silesia","award":["PCN-1-014\/K\/2\/F"],"award-info":[{"award-number":["PCN-1-014\/K\/2\/F"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cancer cells need to carefully regulate their metabolism to keep them growing and dividing under the influence of different nutrients and oxygen levels. Muscle isoform 2 of pyruvate kinase (PKM2) is a key glycolytic enzyme involved in the generation of ATP and is critical for cancer metabolism. PKM2 is expressed in many human tumors and is regulated by complex mechanisms that promote tumor growth and proliferation. Therefore, it is considered an attractive therapeutic target for modulating tumor metabolism. Various modulators regulate PKM2, shifting it between highly active and less active states. In the presented work, a series of 8-quinolinesulfonamide derivatives of PKM2 modulators were designed using molecular docking and molecular dynamics techniques. New compounds were synthesized using the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. Compound 9a was identified in in silico studies as a potent modulator of muscle isoform 2 of pyruvate kinase. The results obtained from in vitro experiments confirmed the ability of compound 9a to reduce the intracellular pyruvate level in A549 lung cancer cells with simultaneous impact on cancer cell viability and cell-cycle phase distribution. Moreover, compound 9a exhibited more cytotoxicity on cancer cells than normal cells, pointing to high selectivity in the mode of action. These findings indicate that the introduction of another quinolinyl fragment to the modulator molecule may have a significant impact on pyruvate levels in cancer cells and provides further directions for future research to find novel analogs suitable for clinical applications in cancer treatment.<\/jats:p>","DOI":"10.3390\/molecules28062509","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:05:54Z","timestamp":1678413954000},"page":"2509","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Design, Synthesis and Biological Evaluation of Quinoline-8-Sulfonamides as Inhibitors of the Tumor Cell-Specific M2 Isoform of Pyruvate Kinase: Preliminary Study"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-2360","authenticated-orcid":false,"given":"Krzysztof","family":"Marciniec","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-0462","authenticated-orcid":false,"given":"Zuzanna","family":"Rzepka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-3444","authenticated-orcid":false,"given":"Elwira","family":"Chrobak","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-6250","authenticated-orcid":false,"given":"Stanis\u0142aw","family":"Boryczka","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Silesia, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Latocha","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-3330","authenticated-orcid":false,"given":"Dorota","family":"Wrze\u015bniok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-3004","authenticated-orcid":false,"given":"Artur","family":"Beberok","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Jagiello\u0144ska 4, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bcp.2004.05.003","article-title":"Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model","volume":"68","author":"Martirosyan","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood-2002-11-3419","article-title":"Quinine as a multidrug resistance inhibitor: A phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia","volume":"102","author":"Solary","year":"2003","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0959-8049(97)10173-3","article-title":"Five days of oral topotecan (hycamtin\u00ae), a phase I and pharmacological study in adult patients with solid tumours","volume":"34","author":"Gerrits","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/1040-8428(96)00211-9","article-title":"The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue","volume":"24","author":"Rowinsky","year":"1996","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/1535-7163.MCT-08-0126","article-title":"SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells","volume":"7","author":"Vultur","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","article-title":"Multikinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 by inhibiting vascular endothelial growth factor receptor (VEGF-R) 2 and VEGF-R3 kinase","volume":"14","author":"Matsui","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-10-2527","article-title":"VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer","volume":"71","author":"You","year":"2011","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1158\/1078-0432.CCR-08-2658","article-title":"Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer","volume":"15","author":"Sparano","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_9","unstructured":"Fenical, W., Jensen, P., MacMillan, J., Hughes, C.C., and LaClair, J.J. (2009). Ammosamides as Anticancer Agents. (2009\/006319), WO. Patent."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4155\/fmc.13.158","article-title":"Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: Novel antipsychotic agents?","volume":"6","author":"Zajdel","year":"2014","journal-title":"Future Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ejmech.2018.01.002","article-title":"Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects","volume":"145","author":"Zajdel","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1021\/jm300612z","article-title":"(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection","volume":"55","author":"Moore","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0960-894X(00)00083-4","article-title":"Synthesis of conformationally constrained analogues of KN62 a potent antagonist of P2X7 receptor","volume":"10","author":"Baraldi","year":"2000","journal-title":"Biorg. Med. Chem. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bcp.2004.12.019","article-title":"G2 arrest and apoptosis by 2-amino-N-quinoline-8-yl-benzenesulfonamide (QBS), a novel cytotoxic compound","volume":"69","author":"Kim","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_15","unstructured":"Bury, M.J., Casillas, L., Charnley, A.K., Demartino, M.P., Dong, X., Haile, P.A., Harris, P.A., Lakdawala, S.A., King, B.W., and Marquis, R.W. (2011). Amino-quinolines as Kinase Inhibitors. (2011\/140442), WO Patent."},{"key":"ref_16","unstructured":"Lindsley, C.W., and Zhao, Z. (2003). Inhibitors of Akt Activity. (2003\/086403), WO Patent."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2049-3002-1-19","article-title":"Quinoline 3-sulfonamides inhibit lactatedehydrogenase A and reverse aerobic glycolysisin cancer cell","volume":"1","author":"Billiard","year":"2013","journal-title":"Cancer Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1016\/j.bmcl.2011.08.114","article-title":"2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"21","author":"Walsh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.chembiol.2012.07.021","article-title":"Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy","volume":"19","author":"Kung","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3892\/ol.2016.4168","article-title":"PKM2 and cancer: The function of PKM2 beyond glycolysis","volume":"11","author":"Dong","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","article-title":"The Warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression","volume":"95","author":"Vaupel","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1349-7006.2010.01562.x","article-title":"Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice","volume":"101","author":"Shi","year":"2010","journal-title":"Cancer Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/iub.1066","article-title":"Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells","volume":"64","author":"Zhou","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","article-title":"Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase","volume":"138","author":"Ning","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2018.05.038","article-title":"PKM2, a potential target for regulating cancer","volume":"668","author":"Li","year":"2018","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12943-018-0791-3","article-title":"Pyruvate kinase M2 fuels multiple aspects of cancer cells: From cellular metabolism, transcriptional regulation to extracellular signalling","volume":"17","author":"Hsu","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.21873\/anticanres.14515","article-title":"Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines","volume":"40","author":"Thonsri","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1042\/BCJ20180171","article-title":"An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor","volume":"475","author":"Yuan","year":"2018","journal-title":"Biochem. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"106112","DOI":"10.1016\/j.ejps.2021.106112","article-title":"Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile","volume":"170","author":"Patel","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/cmdc.202000220","article-title":"Structural Consequences of the 1,2,3-triazole as an amide bioisostere in analogues of the cystic fibrosis drugs VX-809\u2009and VX-770","volume":"15","author":"Doiron","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.1c00981","article-title":"A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2","volume":"65","author":"Arora","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved Protein\u2013Ligand Docking Using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins Struct. Funct. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s12253-019-00715-z","article-title":"Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes","volume":"26","author":"Respondek","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/fcp.12503","article-title":"MIM1 induces COLO829 melanoma cell death through mitochondrial membrane breakdown, GSH depletion, and DNA damage","volume":"34","author":"Respondek","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tiv.2018.08.007","article-title":"MIM1, the Mcl-1\u2014Specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells","volume":"53","author":"Respondek","year":"2018","journal-title":"Toxicol. Vitr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.celrep.2020.01.037","article-title":"Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1\/FAK Signaling Pathway","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1021\/acs.jafc.1c05394","article-title":"Cynaropicrin induces cell cycle arrest and apoptosis by inhibiting PKM2 to cause DNA damage and mitochondrial fission in A549","volume":"69","author":"Ding","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_39","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2016). Gaussian 16, Revision A., Gaussian Inc."},{"key":"ref_40","unstructured":"Cole, J.C., Nissink, J.W.M., and Taylor, R. (2005). Virtual Screening in Drug Discovery, Shoichet, B., Alvarez, J., Eds, CRC Press."},{"key":"ref_41","unstructured":"Syst\u00e8mes, D. (2016). Biovia, Discovery Studio Modeling Environment, Dessault Systemes."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD\u2014Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM General Force Field (CGenFF) II: Assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"Chem. Inf. Model."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"26536","DOI":"10.1038\/srep26536","article-title":"QwikMD\u2014Integrative molecular dynamics toolkit for novices and experts","volume":"6","author":"Ribeiro","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cbdd.14031","article-title":"Synthesis and biological activity profile of novel triazole\/quinoline hybrids","volume":"100","author":"Jamshidi","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10600-013-0702-1","article-title":"Synthesis and study of mutagenic properties of lupane triterpenoids containing 1,2,3-triazole fragments in the C-30 position","volume":"49","author":"Antimonova","year":"2013","journal-title":"Chem. Nat. Compd."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Beberok, A., Wrze\u015bniok, D., Szlachta, M., Rok, J., Rzepka, Z., Respondek, M., and Buszman, E. (2017). Lomefloxacin induces oxidative stress and apoptosis in COLO829 melanoma Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102194"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/6\/2509\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:52:02Z","timestamp":1760122322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/6\/2509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["molecules28062509"],"URL":"https:\/\/doi.org\/10.3390\/molecules28062509","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}